Cite
HARVARD Citation
Murthy, P. et al. (n.d.). The systemic immune-inflammation index (SII) predicts neoadjuvant therapy response and survival in patients with pancreatic cancer who are CA 19-9 non-secretors. HPB. pp. S457-S458. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Murthy, P. et al. (n.d.). The systemic immune-inflammation index (SII) predicts neoadjuvant therapy response and survival in patients with pancreatic cancer who are CA 19-9 non-secretors. HPB. pp. S457-S458. [Online].